• November 18-20, 2019 | Crowne Plaza Boston - Newton, Boston, MA
  • Toll Free: +1 844 395 4102
Early Bird Deadline: Extended Till (March 22, 2019)
Abstract
Register
Download Agenda

Keynote SpeakersVaccines R&D-2019

Rino Rappuoli

Rino Rappuoli

Chief Scientist & Head of External Research and Development, GSK Vaccines

John R. Mascola

John R. Mascola

Director, Vaccine Research Center, NIH/NIAID

Jay A. Berzofsky

Jay A. Berzofsky

Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

Dan H. Barouch

Dan H. Barouch

Director, HMFP - Division of Vaccine Research

Michel De Wilde

Michel De Wilde

Former Senior Vice President R&D of Sanofi Pasteur & Owner, MDW Consultant LLC

Penny M. Heaton

Penny M. Heaton

Chief Executive Officer, Bill & Melinda Gates Medical Research Institute

Stephen L. Hoffman

Stephen L. Hoffman

Chief Executive and Scientific Officer, Sanaria Inc.

Kathy L. Rowlen

Kathy L. Rowlen

Chief Executive and Scientific Officer, InDevR, Inc.

Julie McElrath

Julie McElrath

Director, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Nancy Sullivan

Nancy Sullivan

Chief, Biodefense Research Section, NIH/NIAID

Nathalie Garçon

Nathalie Garçon

Chief Executive and Scientific Officer, IRT BIOASTER

Peter L. Nara

Peter L. Nara

Chairman Emeritus. Chief Executive Officer, President, Chairman & co-founder, Biological Mimetics, Inc.

Norman W. Baylor

Norman W. Baylor

President and Chief Executive Officer, Biologics Consulting

Nikolai Petrovsky

Lawrence Corey

Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Supporting Sponsor

InDevR

InDevR, Inc. is a leader in providing progressive analytical technologies that enhance and accelerate vaccine characterization and production. The company is committed to developing next-generation diagnostic products that will enable unprecedented tracking of seasonal and emerging influenza viruses around the globe.   https://indevr.com/

Early Bird Deadline
Extended
(March 22, 2019) Fast & Easy Online Registration

Group (3 Members)

$ 3000 $ 4700  

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

Delegate

$ 1199 $ 1799  

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

Industry/Company

$ 1099 $ 1699  

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

Academic/Federal

$ 999 $ 1599  

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

2014

Year of Foundation

765

Speakers

125

Business Partners

150

Happy Clients

Testimonials Vaccines R&D-2018

logo1
logo1
logo1
logo1
logo1
logo1

From Our BlogVaccines R&D Blogger

Vaccines R&D-2019
COLOMBIAN MALARIA VACCINE, TO TRIALS IN AFRICA ANNOUNCEMENT WAS MADE AT VACCINES R&D-2016

After 35 years of research, the Colombian scientist Manuel Elkin Patarroyo and his team at the Institute of Immunology of Colombia (FIDIC) s Foundation and ready for human testing its new vaccine against malaria in seven countries in sub – Saharan Africa.

28 November, 2016
Vaccines R&D-2019
REPORT ON THE 3RD INTERNATIONAL CONFERENCE ON VACCINES RESEARCH

The 3rd International Conference on Vaccines Research and Development (Vaccines R&D 2017) at the Sheraton Reston Hotel, Reston located within the Washington, D.C. metropolitan area, brought together more than 250 experts of the leading institutes and organizations to share their knowledge.

7 December, 2017

  • Follow us on:

© 2019 Vaccines R&D-2019. All Rights Reserved | United Scientific Group | Privacy Policy | Terms & Conditions